We detail a key value-based care barrier for health systems as the macroeconomic environment becomes more uncertain.
Kindbody acquired a surrogacy agency as fertility startups like it strike M&A deals and score VC cash, while health techs in primary care flounder.
FTC sues to stop another Meta acquisition: Meta is looking to own a popular VR fitness app, but the FTC says this will kill competition in the metaverse. Is Meta’s innovation by acquisition strategy over?
The true cost of cyberattacks: A recent report shows average losses from hospital data breaches hit $10 million. But with more IoT medical devices deployed, attacks could also cost lives.
Big techs shed their health tech layers: We unpack the latest deal by a large company (3M) to spin off its healthcare business and detail the trend.
New Digital.Health database could help health entities sift through health apps: But if it doesn’t vet health apps’ efficacy, too, will it actually help?
Abbot’s remote treatment clinic platform cleared in Canada: The app can increase remote access and treatment to patients having difficulty receiving care from healthcare providers due to travel.
Could 2022 be the year brain computing tech picks up in healthcare? The market is forecast to hit $3.5B by 2027. We detail how clinical trials could yield new applications to treat epilepsy, communication disorders, and spinal cord injuries.
Here are this week's hottest digital health startups: : Everside Health scores $164M, Health Note nabs $17M.
We explore why Teladoc’s Q2 earnings loss raises question about the Livongo acquisition and detail what the results foreshadow for the US telehealth market.
AI reads the operating room: Surgeries may soon be under AI surveillance as startup Theator expands its video analytics to operating rooms. It could yield helpful insights as well as controversy.
Health systems huddle up on predictive medicine: We detail why large health systems like Mayo Clinic and Mercy are collaborating to advance disease detection.
Digital therapeutics and EHRs go hand in hand: We discuss how a new AmerisourceBergen platform will make e-prescribing DTx through EHRs easier.
Robopill awaits clinical trials…and patient approval: Endiatx’s robotic pill could make medical procedures less invasive, but earning public trust may be difficult. Preempting concerns with transparency could help.
Patients still distrust Big Tech and health tech companies with their data: We unpack the implications around Big Tech health data access, Roe vs. Wade issues and healthcare literacy on the back of a new AMA survey.
Cadence enters the life science market to revolutionize drug discovery: Its OpenEye Scientific acquisition is an example of pharma’s investment in biosimulations for therapeutic research.